Galapagos intends to reorganize its business to focus on long-term value creation in cell therapy in oncology. This is anticipated to lead to a reduction of approximately 300 positions.
All entries for: Galapagos - Mechelen
January 8, 2025
Galapagos - Mechelen
Layoffs
Mechelen, Belgium
501-1,000 employees
Disease Area: Oncology, Rare Diseases
Drug Type: Biologic, Small Molecule